Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3

First patients dosed with BI 3820768 (OB33), marking third programme from the Oxford BioTherapeutics (OBT)-Boehringer Ingelheim collaboration to ...
The BMJ

“Black hole” of medical student funding: NHS trusts have failed to account for over £400m meant for training future doctors

Lack of transparency in how funding from NHS England for undergraduate medical training is spent suggests trusts are treating ...
Morning Overview on MSN

Microplastics build up in the brain at higher levels than in any other organ

Micro- and nanoplastics accumulate in human brain tissue at concentrations significantly higher than in the liver or kidneys, ...

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
ahajournals.org

Perioperative Anemia and Patient Blood Management in Cardiac Surgery: A Scientific Statement From the American Heart Association

Perioperative anemia and red blood cell transfusions are important risk factors for morbidity and mortality in cardiac surgery. Preoperative anemia is common, with up to 50% of patients presenting for ...
Goldseiten

Austral Gold Reports Surface Silver-Gold Results at Juncal

HIGHLIGHTS Exploration of a silver-gold vein system at the 100%-owned Juncal Silver-Gold Project in Chile, near the Amancaya and Guanaco Mines, continued as planned, with Phase 1 completed and Phase 2 ...